Real-World Outcomes with Lomitapide Use in Paediatric Patients with Homozygous Familial HypercholesterolaemiaTawfeg Ben‐Omran, Raúl D. Santos, Martin P. Bogsrud et al.|Advances in Therapy|2019Cited by 53
Single Intravenous Dose of Oritavancin for Treatment of Acute Skin and Skin Structure Infections Caused by Gram-Positive Bacteria: Summary of Safety Analysis from the Phase 3 SOLO StudiesG. Ralph Corey, Paul Manos, Jeffery S. Loutit et al.|Antimicrobial Agents and Chemotherapy|2018Cited by 26
Correction to: Real-World Outcomes with Lomitapide Use in Paediatric Patients with Homozygous Familial HypercholesterolaemiaTawfeg Ben‐Omran, Raúl D. Santos, L. Masana et al.|Advances in Therapy|2024Cited by 0